LOW-DOSE METHOTREXATE (MTX) SUPPRESSES ANTI-GLOBULIN RESPONSES AND POTENTIATES EFFICACY OF A CHIMERIC MONOCLONAL ANTI-TNF-ALPHA ANTIBODY (CA2) GIVEN REPEATEDLY IN RHEUMATOID-ARTHRITIS (RA)
Rn. Maini et al., LOW-DOSE METHOTREXATE (MTX) SUPPRESSES ANTI-GLOBULIN RESPONSES AND POTENTIATES EFFICACY OF A CHIMERIC MONOCLONAL ANTI-TNF-ALPHA ANTIBODY (CA2) GIVEN REPEATEDLY IN RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 40(9), 1997, pp. 571-571